Cargando…

Author Correction: Erythropoietin (EPO) haplotype associated with all-cause mortality in a cohort of Italian patients with Type-2 Diabetes

Detalles Bibliográficos
Autores principales:	Montesanto, Alberto, Bonfigli, Anna Rita, De Luca, Maria, Crocco, Paolina, Garagnani, Paolo, Marasco, Elena, Pirazzini, Chiara, Giuliani, Cristina, Romagnoli, Fabio, Franceschi, Claudio, Passarino, Giuseppe, Testa, Roberto, Olivieri, Fabiola, Rose, Giuseppina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035314/ https://www.ncbi.nlm.nih.gov/pubmed/32081853 http://dx.doi.org/10.1038/s41598-020-59859-7

Ejemplares similares

Erythropoietin (EPO) haplotype associated with all-cause mortality in a cohort of Italian patients with Type-2 Diabetes
por: Montesano, Alberto, et al.
Publicado: (2019)

Genes associated with Type 2 Diabetes and vascular complications
por: Montesanto, Alberto, et al.
Publicado: (2018)

The Genetic Variability of Members of the SLC38 Family of Amino Acid Transporters (SLC38A3, SLC38A7 and SLC38A9) Affects Susceptibility to Type 2 Diabetes and Vascular Complications
por: Crocco, Paolina, et al.
Publicado: (2022)

Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2019)

Further Support to the Uncoupling-to-Survive Theory: The Genetic Variation of Human UCP Genes Is Associated with Longevity
por: Rose, Giuseppina, et al.
Publicado: (2011)

Inter-Individual Variability in Xenobiotic-Metabolizing Enzymes: Implications for Human Aging and Longevity
por: Crocco, Paolina, et al.
Publicado: (2019)

Physical decline and survival in the elderly are affected by the genetic variability of amino acid transporter genes
por: Crocco, Paolina, et al.
Publicado: (2018)

Author Index EPOS, 2015, France
Publicado: (2015)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

Author Index EPOS, 2016, Rome, Italy
Publicado: (2016)

Erythropoietin (EPO) in acute kidney injury
por: Moore, Elizabeth, et al.
Publicado: (2011)

Expression Patterns of Muscle-Specific miR-133b and miR-206 Correlate with Nutritional Status and Sarcopenia
por: Iannone, Francesca, et al.
Publicado: (2020)

Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring
por: Horvath, Steve, et al.
Publicado: (2015)

Bitter Taste Receptor Polymorphisms and Human Aging
por: Campa, Daniele, et al.
Publicado: (2012)

Uncoupling protein 4 (UCP4) gene variability in neurodegenerative disorders: further evidence of association in Frontotemporal dementia
por: Montesanto, Alberto, et al.
Publicado: (2018)

Biomarkers of Frailty: miRNAs as Common Signatures of Impairment in Cognitive and Physical Domains
por: Dato, Serena, et al.
Publicado: (2022)

Circulating miR-181a as a novel potential plasma biomarker for multimorbidity burden in the older population
por: Iannone, Francesca, et al.
Publicado: (2022)

Antioxidants and Quality of Aging: Further Evidences for a Major Role of TXNRD1 Gene Variability on Physical Performance at Old Age
por: Dato, Serena, et al.
Publicado: (2015)

Telomere length as a function of age at population level parallels human survival curves
por: Crocco, Paolina, et al.
Publicado: (2021)

Regulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study
por: Trincavelli, Maria Letizia, et al.
Publicado: (2013)

Centenarians as super-controls to assess the biological relevance of genetic risk factors for common age-related diseases: A proof of principle on type 2 diabetes
por: Garagnani, Paolo, et al.
Publicado: (2013)

Comparison of Neurite Outgrowth Induced by Erythropoietin (EPO) and Carbamylated Erythropoietin (CEPO) in Hippocampal Neural Progenitor Cells
por: Oh, Dong Hoon, et al.
Publicado: (2012)

EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2018)

Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
por: Soliz, Jorge, et al.
Publicado: (2020)

Space/Population and Time/Age in DNA methylation variability in humans: a study on IGF2/H19 locus in different Italian populations and in mono- and di-zygotic twins of different age
por: Pirazzini, Chiara, et al.
Publicado: (2012)

Impact of demography and population dynamics on the genetic architecture of human longevity
por: Giuliani, Cristina, et al.
Publicado: (2018)

Epigenetic Variability across Human Populations: A Focus on DNA Methylation Profiles of the KRTCAP3, MAD1L1 and BRSK2 Genes
por: Giuliani, Cristina, et al.
Publicado: (2016)

Somatic Point Mutations in mtDNA Control Region Are Influenced by Genetic Background and Associated with Healthy Aging: A GEHA Study
por: Rose, Giuseppina, et al.
Publicado: (2010)

The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia
por: Landau, Daniel, et al.
Publicado: (2018)

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
por: Hardee, M E, et al.
Publicado: (2005)

Inositol Polyphosphate Multikinase (IPMK), a Gene Coding for a Potential Moonlighting Protein, Contributes to Human Female Longevity
por: De Rango, Francesco, et al.
Publicado: (2019)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)

Exploring the Role of Genetic Variability and Lifestyle in Oxidative Stress Response for Healthy Aging and Longevity
por: Dato, Serena, et al.
Publicado: (2013)

Structural Identification of Modified Amino Acids on the Interface between EPO and Its Receptor from EPO BRP, Human Recombinant Erythropoietin by LC/MS Analysis
por: Song, Kwang-Eun, et al.
Publicado: (2014)

Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO)
por: Kausar, Humera, et al.
Publicado: (2011)

Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
por: Vetro, Calogero, et al.
Publicado: (2022)

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
por: Awida, Zamzam, et al.
Publicado: (2022)

The epigenetic landscape of age-related diseases: the geroscience perspective
por: Gensous, Noémie, et al.
Publicado: (2017)

Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts
por: Tankiewicz-Kwedlo, A., et al.
Publicado: (2016)

Effects of a novel nutraceutical combination (BruMeChol™) in subjects with mild hypercholesterolemia: study protocol of a randomized, double-blind, controlled trial
por: Bonfigli, Anna Rita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jfbuf9ocqej3fjkefr8dvmc4o5